Real-world evidence (RWE) is increasingly important both for regulatory agencies and reimbursement authorities, providing a way to monitor efficacy, safety, and cost-effectiveness post-launch. For pharmaceutical companies, generating and accessing RWE is critically important as a means of achieving their goals.The post The Increasing Importance of Generating and Accessing Real-World Evidence appeared first on Pharmaspectra.
Pharmaspectra is a New York-based health information platform that provides solutions such as scientific data, KOL mapping, and impact measurement for the pharmaceutical sector.